BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28632105)

  • 1. Obstacle Avoidance Increases Asymmetry of Crossing Step in Individuals With Parkinson's Disease and Neurologically Healthy Individuals.
    Barbieri FA; Simieli L; Orcioli-Silva D; Baptista AM; Borkowske Pestana M; Spiandor Beretta V; Dos Santos PCR; Bucken Gobbi LT
    J Mot Behav; 2018; 50(1):17-25. PubMed ID: 28632105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Activity Underlying Gait Improvements Achieved With Dopaminergic Medication During Usual Walking and Obstacle Avoidance in Parkinson Disease.
    Orcioli-Silva D; Vitório R; Nóbrega-Sousa P; Beretta VS; Conceição NRD; Oliveira AS; Pereira MP; Gobbi LTB
    Neurorehabil Neural Repair; 2021 May; 35(5):406-418. PubMed ID: 33754884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait & Posture Special Issue: Gait adaptations in response to obstacle type in fallers with Parkinson's disease.
    Alcock L; Galna B; Hausdorff JM; Lord S; Rochester L
    Gait Posture; 2018 Mar; 61():368-374. PubMed ID: 29448219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking behavior over multiple obstacles in people with Parkinson's disease.
    Orcioli-Silva D; Barbieri FA; Simieli L; Vitorio R; Santos PCRD; Beretta VS; Gobbi LTB
    Gait Posture; 2017 Oct; 58():510-515. PubMed ID: 28957776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Neuroscience; 2016 Mar; 318():219-29. PubMed ID: 26794593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstacle circumvention and eye coordination during walking to least and most affected side in people with Parkinson's disease.
    Barbieri FA; Polastri PF; Gobbi LTB; Simieli L; Pereira VIA; Baptista AM; Moretto GF; Fiorelli CM; Imaizumi LFI; Rodrigues ST
    Behav Brain Res; 2018 Jul; 346():105-114. PubMed ID: 29180136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective measures of unobstructed walking and obstacle avoidance in Parkinson's disease subtypes.
    Orcioli-Silva D; Vitório R; Lirani-Silva E; Santos PCR; Beretta VS; Gobbi LTB
    Gait Posture; 2018 May; 62():405-408. PubMed ID: 29627500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural instability and gait impairment during obstacle crossing in Parkinson's disease.
    Stegemöller EL; Buckley TA; Pitsikoulis C; Barthelemy E; Roemmich R; Hass CJ
    Arch Phys Med Rehabil; 2012 Apr; 93(4):703-9. PubMed ID: 22318131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double obstacles increase gait asymmetry during obstacle crossing in people with Parkinson's disease and healthy older adults: A pilot study.
    Orcioli-Silva D; Barbieri FA; Dos Santos PCR; Beretta VS; Simieli L; Vitorio R; Lirani-Silva E; Gobbi LTB
    Sci Rep; 2020 Feb; 10(1):2272. PubMed ID: 32042027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstacle crossing in Parkinson's disease: mediolateral sway of the centre of mass during level-ground walking and obstacle crossing.
    Galna B; Murphy AT; Morris ME
    Gait Posture; 2013 Sep; 38(4):790-4. PubMed ID: 23647655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstacle crossing in people with Parkinson's disease: foot clearance and spatiotemporal deficits.
    Galna B; Murphy AT; Morris ME
    Hum Mov Sci; 2010 Oct; 29(5):843-52. PubMed ID: 19962206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease severity affects obstacle crossing in people with Parkinson's disease.
    Vitório R; Lirani-Silva E; Baptista AM; Barbieri FA; dos Santos PC; Teixeira-Arroyo C; Gobbi LT
    Gait Posture; 2014; 40(1):266-9. PubMed ID: 24671005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variability of the steps preceding obstacle avoidance (approach phase) is dependent on the height of the obstacle in people with Parkinson's disease.
    Simieli L; Gobbi LTB; Orcioli-Silva D; Beretta VS; Santos PCR; Baptista AM; Barbieri FA
    PLoS One; 2017; 12(9):e0184134. PubMed ID: 28910314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaze and motor behavior of people with PD during obstacle circumvention.
    Simieli L; Vitório R; Rodrigues ST; Zago PFP; Ignacio Pereira VA; Baptista AM; de Paula PHA; Penedo T; Almeida QJ; Barbieri FA
    Gait Posture; 2017 Oct; 58():504-509. PubMed ID: 28950250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the acute contributions of dopaminergic replacement to gait with obstacles in Parkinson's disease.
    Pieruccini-Faria F; Vitório R; Almeida QJ; Silveira CR; Caetano MJ; Stella F; Gobbi S; Gobbi LT
    J Mot Behav; 2013; 45(5):369-80. PubMed ID: 23834709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstacle crossing following stroke improves over one month when the unaffected limb leads, but not when the affected limb leads.
    Said CM; Galea M; Lythgo N
    Gait Posture; 2014 Jan; 39(1):213-7. PubMed ID: 23916414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of arm swing during gait among Parkinson's disease patients.
    Sterling NW; Cusumano JP; Shaham N; Piazza SJ; Liu G; Kong L; Du G; Lewis MM; Huang X
    J Parkinsons Dis; 2015; 5(1):141-50. PubMed ID: 25502948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Eur J Neurosci; 2015 Aug; 42(4):2028-35. PubMed ID: 25899750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of obstacle height on obstacle crossing in mild Parkinson's disease.
    Vitório R; Pieruccini-Faria F; Stella F; Gobbi S; Gobbi LT
    Gait Posture; 2010 Jan; 31(1):143-6. PubMed ID: 19854057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of habitual footwear in gait outcomes in people with Parkinson's disease.
    Pereira MP; Orcioli-Silva D; de Sousa PN; Beretta VS; Gobbi LTB
    Gait Posture; 2019 Feb; 68():111-114. PubMed ID: 30471619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.